Table: Shin Nippon Biomedical -2024/25 group results

Shin Nippon Biomedical Laboratories

08/05/2025 01:00

May 8 (Reuters)- 
          Shin Nippon Biomedical Laboratories Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to        NEXT    
              Mar 31, 2025    Mar 31, 2024   Mar 31, 2026      YEAR      
                 LATEST         YEAR-AGO        COMPANY       COMPANY    
                 RESULTS         RESULTS       FORECAST     H1 FORECAST  
  Sales           32.41           26.45          33.27         14.54     
               (+22.5 pct)     (+5.4 pct)     (+2.6 pct)    (+16.3 pct)  
  Operating        2.99            4.16           3.55      loss 97 mln  
               (-28.3 pct)     (-20.6 pct)    (+18.9 pct)                
  Recurring        6.45            7.02           5.93          1.18     
               (-8.1 pct)      (-23.7 pct)    (-8.1 pct)    (-35.5 pct)  
  Net
  Net              4.92            5.53           3.55      loss 183 mln 
               (-11.0 pct)     (-8.7 pct)     (-27.9 pct)                
  EPS          118.29 yen      132.86 yen      85.27 yen   loss 4.39 yen 
  Ann Div       50.00 yen       50.00 yen      50.00 yen                 
  -Q2 Div       20.00 yen       20.00 yen      20.00 yen                 
  -Q4 Div       30.00 yen       30.00 yen      30.00 yen                 
  
  NOTE - Shin Nippon Biomedical Laboratories Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T